克洛弗健康投资公司（NASDAQ:CLOV）报告季度每股亏损$(0.04)，比分析师预期的$(0.07)高42.86%。 这比去年同期每股亏损$(0.14)增加了71.43%。公司报告季度销售额为$3.3696亿，低于分析师预期$3.8255亿，低11.92%。这比去年同期的$3.1238亿销售额增长了7.87%。
以上内容来自Benzinga Earnings专栏，原文如下：
Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 71.43 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $336.96 million which missed the analyst consensus estimate of $382.55 million by 11.92 percent. This is a 7.87 percent increase over sales of $312.38 million the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.